Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantation

Area of Science:

• Nephrology
• Immunology
• Transplantation Medicine

Background:

• Chronic kidney disease (CKD) is a major global health issue.
• Kidney transplantation is the preferred treatment for end-stage kidney disease.
• Long-term kidney graft survival and patient mortality remain significant challenges despite advances.

Purpose of the Study:

• To review emerging therapeutic strategies for improving long-term kidney transplant outcomes.
• To analyze current evidence and identify knowledge gaps in immunosuppressive therapies.
• To address the need for safer and more effective treatments for kidney transplant recipients.

Main Methods:

• Literature review of recent studies on novel immunosuppressive agents.
• Analysis of clinical trial data and observational studies.
• Synthesis of evidence on therapeutic approaches for long-term graft survival.

Main Results:

• Short-term kidney allograft survival has improved, but long-term outcomes show limited progress.
• High rates of death with a functioning allograft persist.
• Existing immunosuppressive regimens have safety concerns impacting long-term use.

Conclusions:

• There is a critical need for novel immunosuppressive agents to enhance long-term kidney transplant success.
• Further research is required to address conflicting findings and knowledge gaps in therapeutic strategies.
• Optimizing long-term safety and efficacy is paramount for improving patient survival and graft longevity.